Related Articles
hsa-miR-631 resensitizes bortezomib-resistant multiple myeloma cell lines by inhibiting UbcH10
The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells
shRNA-mediated Bmi-1 silencing sensitizes multiple myeloma cells to bortezomib
Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiation
Downregulation of DCC sensitizes multiple myeloma cells to bortezomib treatment